Red Light Therapy — Which Wavelengths Actually Do Something
The $1.6 billion red light therapy industry runs on bold claims. But photobiomodulation is real science — certain wavelengths genuinely affect mitochondrial function. Here's what the evidence shows.
The Study (In Plain English)
In 2018, Michael Hamblin at Harvard Medical School published a comprehensive review of photobiomodulation (PBM) — the scientific term for using specific wavelengths of light to affect biological tissue. He synthesized decades of research into how red and near-infrared light interact with cells.
The core mechanism: Light in the red (620-700nm) and near-infrared (700-1100nm) range penetrates skin and is absorbed by cytochrome c oxidase, an enzyme in the mitochondrial electron transport chain. This absorption increases ATP (energy) production, reduces oxidative stress, and triggers beneficial signaling cascades.
This is not pseudoscience. It's photochemistry — the same principle by which UV light causes sunburn or blue light sets your circadian clock.
Which Wavelengths Matter
Not all light is equal. The research consistently identifies two therapeutic windows:
| Wavelength Range | Type | Penetration | Primary Target |
|---|---|---|---|
| 630-670nm | Red (visible) | ~8-10mm into tissue | Skin, superficial wounds, joints |
| 810-850nm | Near-infrared (invisible) | ~30-40mm into tissue | Deep tissue, muscle, brain, bone |
The sweet spots:
- 633nm — Most studied for skin conditions and wound healing
- 660nm — Strong evidence for collagen production and inflammation
- 810nm — Best evidence for deep tissue penetration, brain photobiomodulation
- 850nm — Muscle recovery, joint pain, deep inflammation
What doesn't work:
- Wavelengths below 600nm — Absorbed by hemoglobin and melanin before reaching target tissue
- Wavelengths above 1100nm — Absorbed by water in tissue, generate heat instead of photobiomodulation
- Blue or green "healing" lights — Different mechanism entirely (antimicrobial for blue, not the same as PBM)
What the Evidence Supports
Strong evidence:
Wound healing and tissue repair. NASA originally funded PBM research in the 1990s to help astronauts heal from injuries in space. Multiple RCTs show that red/NIR light accelerates wound closure, reduces scar formation, and speeds recovery from surgery. A 2014 Cochrane review found moderate evidence for PBM in oral mucositis (mouth sores from chemotherapy).
Joint pain and osteoarthritis. A 2019 meta-analysis by Stausholm et al. in BMJ Open Sport & Exercise Medicine found that PBM significantly reduced pain and improved function in knee osteoarthritis — with effect sizes comparable to NSAIDs but without the gastrointestinal side effects.
Muscle recovery. A 2018 meta-analysis by Vanin et al. found that PBM applied before exercise significantly enhanced performance and reduced markers of muscle damage and delayed-onset muscle soreness (DOMS). The optimal timing was 5-6 hours before exercise.
Moderate evidence:
Skin rejuvenation. Several RCTs show improvements in skin roughness, wrinkle depth, and collagen density after 12-20 weeks of red light treatment (typically 633nm). A 2014 study by Wunsch and Matuschka found significant improvements in skin complexion and collagen density with 630nm and 830nm treatment.
Traumatic brain injury. Naeser et al. (2014) published case studies showing improved cognitive function in chronic TBI patients treated with transcranial NIR light (810nm). Controlled trials are underway, but the preliminary results are intriguing — light appears to reduce neuroinflammation and promote neuronal repair.
Hair growth. Several RCTs show that 650-655nm light significantly increases hair density and thickness in androgenetic alopecia. The FDA has cleared multiple laser hair growth devices based on this evidence.
Weak or preliminary evidence:
Depression and anxiety. Transcranial PBM (810nm applied to the forehead) has shown promise in a handful of small studies for major depressive disorder. The hypothesis: NIR light reaches the prefrontal cortex and enhances mitochondrial function in neurons. Interesting but far from proven.
Thyroid function. A 2013 Brazilian RCT found that PBM reduced the need for thyroid medication in Hashimoto's thyroiditis patients. Needs replication.
Fat loss. Some studies suggest PBM can transiently affect adipocyte (fat cell) permeability. The clinical significance is questionable, and the marketing around "red light for weight loss" dramatically outstrips the evidence.
The Consumer Product Problem
The red light therapy market is flooded with devices ranging from $30 handheld wands to $3,000 full-body panels. Most do not provide adequate information about:
- Irradiance (power density in mW/cm²) — The most critical parameter. Clinical studies typically use 10-50 mW/cm² at the tissue surface. Many consumer devices deliver far less.
- Wavelength verification — Cheap devices may claim 660nm but actually emit a spread of wavelengths, some of which are therapeutically irrelevant.
- Treatment time and distance — Effective dose depends on all three: power density × time × distance from the device.
A device that delivers 660nm at 50 mW/cm² from 6 inches away for 10 minutes provides a very different dose than one emitting the same wavelength at 5 mW/cm² from 3 feet away.
Most consumer products don't publish their irradiance data at clinically relevant distances. If a company can't tell you the power density at the treatment surface, they can't tell you whether the device works.
The Honest Take
Photobiomodulation is real. Specific wavelengths of light genuinely affect mitochondrial function, and this has downstream effects on healing, inflammation, and pain. The mechanism is well-characterized, and the evidence for certain applications (wound healing, joint pain, muscle recovery) is solid enough to have entered clinical practice.
But the consumer market has taken a legitimate scientific phenomenon and wrapped it in marketing that the evidence can't support. "Anti-aging," "detox," "fat-melting" red light therapy panels are selling a fantasy version of a real intervention.
If you're interested in PBM, look for: (1) verified wavelengths of 660nm and/or 850nm, (2) published irradiance data, (3) specific treatment protocols based on published research, and (4) claims that match the evidence, not the hype.
Sources: Hamblin, "Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation," AIMS Biophysics, 2017. Stausholm et al., "Efficacy of Low-Level Laser Therapy on Pain and Disability in Knee Osteoarthritis," BMJ Open Sport & Exercise Medicine, 2019. Vanin et al., "Photobiomodulation for Skeletal Muscle Exercise Performance," British Journal of Sports Medicine, 2018.